Clinical Trial Update: GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GPC3-targeted CAR-T cell therapy in advanced GPC3-expressing solid tumors, including hepatocellular carcinoma and metastatic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GPC3-targeted CAR-T cell therapy (GPC3-targeted CAR-T)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 1 | Status: RECRUITING